Therapeutic-area Dossier
Haematology
Therapeutic-area Dossier for Haematology (blood medicines). Australian brands, active ingredients, PBS-listed treatments, PBAC outcomes — compiled by…
- Brand: ADCETRIS
- Brand: ARANESP
- Brand: ARIXTRA
- Brand: CALQUENCE
- Brand: Deferasirox Juno
- Brand: DOPTELET
- Sponsor: CSL Behring
- Sponsor: Takeda Pharmaceuticals
- Sponsor: Pfizer
- Sponsor: Arrotex Pharmaceuticals
What is
Haematology Haematology is a therapeutic area with 167 brands registered in Australia. The area encompasses medicines used in the diagnosis, treatment and management of blood disorders and haematological conditions.
Brands registered in Haematology The top brands registered in this area are:
— APO-AZATHIOPRINE — BESPONSA — CLEXANE — Deferasirox Juno — DOPTELET — FERINJECT — FERRIPROX — ICLUSIG — INREBIC — JADENU — MEGAFOL — MIRCERA
Sponsor landscape
The haematology therapeutic area has 56 active sponsors, with CSL Behring, Takeda Pharmaceuticals, Arrotex Pharmaceuticals, Medsurge Pharma, Sandoz, AFT Pharmaceuticals, Sanofi-Aventis and Pfizer among the top sponsors.
PBS and regulatory activity
There are 21 brands with PBS-listed items in haematology, with the latest PBS schedule dated 1 May 2026. The latest PBAC outcome in this area is from 1 November 2025, with 22 brands having PBAC outcomes on record. The most recent AusPAR is dated 12 February 2025, with 29 brands holding AusPARs on record.